Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Corteva, Inc.    CTVA

CORTEVA, INC.

(CTVA)
  Report
Delayed Quote. Delayed Nyse - 11/23 04:10:00 pm
37.79 USD   +1.70%
11/19CORTEVA : Press Release ()
PU
11/19CORTEVA : Presentation ()
PU
11/18CORTEVA : Pioneer® Brand Corn and Soybean Product Performance Drives Long-term Business Ad
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Corteva, Inc.
Corteva, Inc. specializes in the manufacturing and marketing of agricultural and phytosanitary products. Net sales break down by activity as follows:

- production of seed and grain (54.8%): mainly corn seeds (67.3% of net sales) and soybeans (18.1%);

- manufacture of crop protection products (45.2%): insecticides (52.3% of sales), herbicides (26.4%), fungicides (17.3%) and other (4%).

At the end of 2019, the group had 104 production sites worldwide.

Net sales are distributed geographically as follows: the United States (45.2%), Latin America (20.8%), Europe/Middle East/Africa (19.8%), Asia/Pacific (9.3%) and Canada (4.9%).
Sales per Business
2019
USD (in Million)%
Corn5,11136.9%
Herbicides3,27023.6%
Insecticides1,65211.9%
Soybean1,3719.9%
Fungicides1,0817.8%
Other Oilseeds561.004.1%
Other Seed547.004%
Other Crop Protection253.001.8%
Sales per region
2019
USD (in Million)%
United States6,25545.2%
EMEA2,74019.8%
Brazil1,79413%
Asia Pacific1,2889.3%
Latin America1,0957.9%
Canada674.004.9%
Managers
NameAgeSinceTitle
James Collins56-Chief Executive Officer & Director
Gregory Page67-Non-Executive Chairman
Gregory R. Friedman522018Chief Financial Officer & Executive Vice President
Debra King-2017Chief Information Officer & Senior Vice President
Sam Eathington, Dr.-2020Chief Technology Officer & Senior Vice President
Marcos Marinho Lutz502019Independent Director
Lamberto Andreotti70-Independent Director
Robert A. Brown, Dr.67-Independent Director
Klaus A. Engel, Dr.63-Independent Director
Michael O. Johanns68-Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 745,016,000 744,356,257 99.9% 0 0.0% 99.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 71,928,723 9.61%
SSgA Funds Management, Inc. 42,612,197 5.69%
Aristotle Capital Management LLC 25,651,177 3.43%
Barrow, Hanley, Mewhinney & Strauss LLC 21,253,420 2.84%
Independent Franchise Partners LLP 20,713,233 2.77%
Invesco Advisers, Inc. 19,773,666 2.64%
BlackRock Fund Advisors 17,764,830 2.37%
Northern Trust Investments, Inc.(Investment Management) 12,581,845 1.68%
Geode Capital Management LLC 12,393,153 1.66%
Starboard Value LP 11,710,329 1.56%
Holdings
NameEquities%Valuation
Royalty Pharma plc (RPRX) 856,1100.23%31,419,237 USD
Royalty Pharma PLC Class B 83,9400.035%3,080,598 USD
Royalty Pharma Plc 83,9400.039%3,080,598 USD
Markets and indexes
- NYSE
- Main Market
- SP 500 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  CTVA.N
- Datastream Code :  
Company contact information
Corteva, Inc.


États-Unis (les)

Phone : +1
Fax : +1
web site : https://investors.corteva.com/home/default.aspx
Brand Portfolio
In partnership withAllbrands.markets
More brands of Corteva, Inc.